Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Moodys
Dow
Johnson and Johnson
Baxter
Merck
Colorcon

Last Updated: October 15, 2019

DrugPatentWatch Database Preview

Ingenus Pharms Llc Company Profile

See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for INGENUS PHARMS LLC, and what generic and branded alternatives to INGENUS PHARMS LLC drugs are available?

INGENUS PHARMS LLC has seventeen approved drugs.



Summary for Ingenus Pharms Llc
US Patents:0
Tradenames:17
Ingredients:17
NDAs:17

Drugs and US Patents for Ingenus Pharms Llc

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ingenus Pharms Llc CABERGOLINE cabergoline TABLET;ORAL 204735-001 Aug 1, 2018 AB RX No No   See Pricing   See Pricing
Ingenus Pharms Llc FENOFIBRATE (MICRONIZED) fenofibrate CAPSULE;ORAL 207564-002 Apr 19, 2019 AB RX No No   See Pricing   See Pricing
Ingenus Pharms Llc LEUCOVORIN CALCIUM leucovorin calcium INJECTABLE;INJECTION 210917-001 Nov 23, 2018 AP RX No No   See Pricing   See Pricing
Ingenus Pharms Llc CARBOPLATIN carboplatin INJECTABLE;INTRAVENOUS 208487-001 Apr 26, 2017 AP RX No No   See Pricing   See Pricing
Ingenus Pharms Llc CARBOPLATIN carboplatin INJECTABLE;INTRAVENOUS 208487-003 Apr 26, 2017 AP RX No No   See Pricing   See Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
Mallinckrodt
Colorcon
Express Scripts
McKinsey
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.